The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
NPA released a press release, last week, commending the action by DEA. 'The association has maintained all along that federal regulators have the authority they need [to schedule these substances],'ÃÂ said John Gay, executive director and CEO of NPA. 'The DEA...s listing of these three steroids demonstrates that federal regulators can indeed safeguard the shelves against these substances.'ÃÂ
The classified substances received increased scrutiny during talks at a September Senate hearing on 'hidden steroids'ÃÂ held by the Senate Subcommittee on Crime and Drugs. DEA first received notice for proposed rulemaking on the substances in April 2008. The agency also states that, since August 2008, it has been aware of 58 dietary supplements believed to contain one or more of these substances.
DEA...s full announcement can be read here
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.